Intelligent Bio Solutions Inc. — Company profile
Healthcare · Medical Devices · United States
Last price 1.83 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 5.54M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. Intelligent Bio Solutions Inc. was incorporated in 2016 and is headquartered in New York, New York.
Details
| Name | Intelligent Bio Solutions Inc. |
| Sector | Healthcare |
| Industry | Medical Devices |
| Employees | 60 |
| Founded | 2016 |
| Ceo | Harry Simeonidis |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| Isin | US36151G7097 |
| Cusip | 36151G709 |
| Cik | 1725430 |
| Sic | 3841 |
Key executives
| Name | Title |
|---|---|
| Harry Simeonidis | President and Chief Executive Officer |
| Spiro Kevin Sakiris B.Bus, C.A., Dip Law | Chief Financial Officer |
| Callistus Sequeira | Vice President of Global Quality and Operations |
| Doug Heath | Vice President of Global Sales |
| Anna Turkington | Vice President of Marketing |
| Valter Pinto | Managing Director of KCSA Strategic Communications |
| Peter Passaris | Vice President of Product Development |
Contact
| Address | 135 West, 41st Street, 5th Floor, New York, New York 10036, United States |
| Phone | 646 828 8258 |
| Website | https://ibs.inc |